Executive Summary
On 6 October 2026, the European Chemicals Agency's Committee for Risk Assessment (RAC) published its final opinion recommending harmonised classification of trifluoroacetic acid (TFA) and its inorganic salts as toxic to reproduction (Category 1B for adverse effects on development, Category 2 for adverse effects on sexual function and fertility), persistent mobile toxic (PMT), and very persistent very mobile (vPvM). This is the first substance to receive PMT and vPvM classifications under the CLP Regulation. While TFA is not a tattoo ink ingredient, it is a terminal breakdown product of certain PFAS—and the classification cascade it triggers has direct implications for REACH compliance throughout the body art supply chain.
1. The Opinion: What RAC Decided
RAC's opinion (ECHA/RAC/CLH-O-0000007126-85-01/F), adopted at its 77th plenary meeting in June 2026 and formally published on 6 October 2026, recommends the following harmonised classifications for TFA (CAS 76-05-1, EC 200-929-3) and its inorganic salts including sodium trifluoroacetate (CAS 2923-18-4):
- Repr. 1B, H360Df—May damage the unborn child. Suspected of damaging fertility.
- PMT, EUH450—Persistent, mobile and toxic substance.
- vPvM, EUH451—Very persistent and very mobile substance.
- Acute Tox. 3 (inhalation), H331—Upgraded from Category 4, ATE 3 mg/L (vapours).
- Acute Tox. 4 (oral), H302—ATE 500 mg/kg bw.
- EUH071—Corrosive to the respiratory tract (TFA only).
Existing classifications retained: Skin Corr. 1A (H314), Aquatic Chronic 3 (H412).
The opinion was based on a CLH proposal from Germany. RAC concluded that TFA and its salts break down in the body and environment into elements causing largely the same toxic effects. The environmental concern is particularly long-term: TFA is extremely persistent, highly mobile in water, and leads to widespread, very long-lasting contamination of groundwater.
2. Why This Matters for Body Art
The PFAS Connection
REACH Annex XVII Entry 75 (EU 2020/2081) restricts PFAS in tattoo inks and permanent make-up. The restriction covers over 4,000 substances, including PFAS that degrade to TFA. TFA itself is not listed in Entry 75—but the CLP classification cascade changes the regulatory terrain:
1. Repr. 1B → SVHC identification—Under REACH Article 57(c), substances classified as Repr. 1A/1B are Substances of Very High Concern. Once the CLP amendment is adopted, TFA and its salts become SVHCs automatically.
2. SVHC → Authorisation (Annex XIV)—SVHCs are prioritised for inclusion in the Authorisation List. If listed, use requires authorisation—a burden no tattoo ink manufacturer would accept for a breakdown product.
3. PMT/vPvM → Generic restriction pathway—The 2023 CLP amendment introduced PMT/vPvM hazard classes specifically to enable group-based restrictions for mobile persistent substances. TFA is the first test case.
Practical Consequences for Suppliers and Studios
Ink manufacturers must now: (a) screen formulations for PFAS precursors that degrade to TFA, (b) prepare for SDS updates once the CLP amendment enters force, (c) anticipate REACH restriction proposals targeting PMT/vPvM substances as a group.
Distributors and studios should: (a) request updated SDS from all ink suppliers within 6 months of the CLP amendment, (b) verify that PFAS declarations cover precursor substances, not just terminal PFAS, (c) monitor ECHA's restriction intentions list for PMT/vPvM group restrictions.
3. The Regulatory Cascade Explained
```
CLP Harmonised Classification (Repr. 1B, PMT, vPvM)
↓
REACH Article 57(c) → SVHC Candidate List (automatic)
↓
REACH Article 58 → Annex XIV Prioritisation → Authorisation
↓
REACH Article 68 → Annex XVII Restriction (generic PMT/vPvM route)
```
This cascade is not theoretical. The European Commission's Chemicals Strategy for Sustainability explicitly targets PMT/vPvM substances for group restrictions. TFA's classification as the first PMT/vPvM substance establishes the precedent.
4. What Studios Should Do Now
1. Audit your ink SDS library—Flag any product with PFAS declarations or fluorinated ingredients.
2. Request TFA-precursor screening data—Ask manufacturers for analytical data on PFAS content and degradation pathways.
3. Update your REACH compliance file—Ensure your REACH Guard or equivalent compliance report includes SVHC monitoring for TFA and its salts.
4. Monitor the CLP amendment—Track the delegated act through the Official Journal; once published, SDS updates are required within the transition period.
5. Engage your supplier—A proactive conversation about PFAS precursor screening positions you ahead of enforcement.
5. The Bigger Picture
TFA is everywhere—in rainwater, groundwater, and human blood. Its classification as PMT/vPvM signals a regulatory shift: persistence and mobility are now standalone hazard criteria, not just factors in PBT/vPvB assessment. For body art, this means the regulatory perimeter is expanding from "what's in the bottle" to "what the bottle's ingredients become in the environment."
The June 2026 toxicology data (Komane, Protano) already moved the needle from compositional limits to exposure-based risk assessment. The October 2026 TFA classification extends that logic upstream: if a substance's breakdown product is a reproductive toxicant that contaminates water irreversibly, the precursor substance faces regulatory pressure regardless of its own hazard profile.
Bottom line: The TFA opinion is a signal, not a ban. But it is the clearest signal yet that PFAS chemistry—including degradation products—is in the regulatory crosshairs. Studios that document their PFAS due diligence now will be ahead when the inevitable restriction proposals arrive.
---
Technical References
1. European Chemicals Agency. ECHA recommends TFA's classification as a reprotoxic substance. ECHA/NR/26/28, 6 October 2026.
2. European Chemicals Agency. RAC opinion on trifluoroacetic acid and its inorganic salts. ECHA/RAC/CLH-O-0000007126-85-01/F.
3. European Commission. Regulation (EC) No 1272/2008 (CLP Regulation), consolidated 2026.
4. European Chemicals Agency. REACH Annex XVII Entry 75: Tattoo Inks and Permanent Make-Up.
5. German Environment Agency. CLH proposal for trifluoroacetic acid, 2024.
TFA itself is not currently listed in REACH Annex XVII Entry 75, which restricts PFAS in tattoo inks and permanent make-up under Regulation (EU) 2020/2081. However, TFA is a terminal breakdown product of many PFAS covered by Entry 75's 4,000-plus substance list, and once the CLP harmonised classification is adopted, its Repr. 1B status will trigger automatic SVHC identification under REACH Article 57(c). That means formulators cannot treat TFA as out of scope simply because it isn't named in Entry 75. PMT stands for Persistent, Mobile and Toxic, and vPvM for Very Persistent and Very Mobile—new hazard classes introduced by the 2023 CLP amendment specifically to address substances that contaminate groundwater. RAC's October 2026 opinion assigned TFA EUH450 (PMT) and EUH451 (vPvM), making it the first substance ever classified under these endpoints. The environmental concern is acute: TFA is extremely persistent and highly mobile in water, leading to widespread, long-lasting groundwater contamination. Not immediately—the RAC opinion must first be transposed into a binding CLP amendment before SDS obligations change. Once that amendment enters force, studios and distributors should request updated SDS from all ink suppliers within 6 months, as advised in the article. Pay particular attention to whether suppliers' PFAS declarations cover precursor substances that degrade to TFA, not just terminal PFAS. The regulatory cascade runs from CLP harmonised classification (Repr. 1B, PMT, vPvM) to automatic SVHC Candidate List entry under REACH Article 57(c), then Annex XIV prioritisation and authorisation under Article 58, and finally Annex XVII restriction via the generic PMT/vPvM route under Article 68. TFA is effectively the first test case for group-based restrictions enabled by the 2023 CLP amendment's new mobile persistent hazard classes. Ink manufacturers should anticipate restriction proposals targeting PMT/vPvM substances as a group rather than TFA alone. Yes—RAC upgraded the inhalation classification from Category 4 to Acute Tox. 3 (H331) with an ATE of 3 mg/L for vapours, which is significantly more stringent than the oral classification of Acute Tox. 4 (H302) at an ATE of 500 mg/kg bw. TFA also carries EUH071 (corrosive to the respiratory tract) and retains Skin Corr. 1A (H314). These are occupational-exposure concerns for formulators handling bulk materials rather than typical finished-ink exposure in a studio setting.FAQ
Is TFA actually banned in tattoo ink under REACH?
What does PMT classification mean and why is TFA the first substance to get it?
Do I need to update my studio's safety data sheets because of the TFA opinion?
How does an SVHC listing for TFA lead to a restriction on body art materials?
Is TFA more dangerous to inhale than to swallow?


